Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
M.B.B.S., M.D.
Gastroenterologist
M.B.B.S., M.R.C.P (UK), F.R.C.P (UK), CCST GASTROENTEROLOGY/HEPATOLOGY/GENERAL MEDICINE
Gastroenterologist
M.B.B.S., M.R.C.P (UK), F.R.C.P (UK), CCST GASTROENTEROLOGY/HEPATOLOGY/GENERAL MEDICINE
Endocrinologist
M.B.B.S, F.C.P.S (Medicine), F.C.P.S (Endocrinology)
Gastroenterologist
M.B.B.S., F.C.P.S.
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), OJT Rheumatology, FCPS Rheumatology
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine), OJT Rheumatology, FCPS Rheumatology
Gastroenterologist
M.B.B.S, F.C.P.S. (Gastroenterology)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures